- Home
- PCQ vs THRD Comparison
PCQ vs THRD Comparison
Compare PCQ & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCQ
- THRD
- Stock Information
- Founded
- PCQ 2001
- THRD 2019
- Country
- PCQ United States
- THRD United States
- Employees
- PCQ N/A
- THRD N/A
- Industry
- PCQ Investment Managers
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- PCQ Finance
- THRD Health Care
- Exchange
- PCQ Nasdaq
- THRD Nasdaq
- Market Cap
- PCQ N/A
- THRD 164.2M
- IPO Year
- PCQ N/A
- THRD 2022
- Fundamental
- Price
- PCQ $8.73
- THRD $5.15
- Analyst Decision
- PCQ
- THRD Hold
- Analyst Count
- PCQ 0
- THRD 3
- Target Price
- PCQ N/A
- THRD $5.00
- AVG Volume (30 Days)
- PCQ 69.6K
- THRD 1.1M
- Earning Date
- PCQ 01-01-0001
- THRD 05-19-2025
- Dividend Yield
- PCQ 4.63%
- THRD N/A
- EPS Growth
- PCQ N/A
- THRD N/A
- EPS
- PCQ N/A
- THRD N/A
- Revenue
- PCQ N/A
- THRD N/A
- Revenue This Year
- PCQ N/A
- THRD N/A
- Revenue Next Year
- PCQ N/A
- THRD N/A
- P/E Ratio
- PCQ N/A
- THRD N/A
- Revenue Growth
- PCQ N/A
- THRD N/A
- 52 Week Low
- PCQ $8.19
- THRD $3.18
- 52 Week High
- PCQ $10.50
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- PCQ 56.98
- THRD 76.77
- Support Level
- PCQ $8.65
- THRD $5.13
- Resistance Level
- PCQ $8.77
- THRD $5.25
- Average True Range (ATR)
- PCQ 0.11
- THRD 0.05
- MACD
- PCQ 0.05
- THRD -0.03
- Stochastic Oscillator
- PCQ 88.33
- THRD 41.18
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.